Abbott Cuts 1,900 Jobs in Restructuring of Drug Unit

Abbott Laboratories, maker of the rheumatoid arthritis drug Humira, said it will cut about 1,900 jobs as part of a restructuring of its pharmaceutical business.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.